A clinical data validated mathematical model of prostate cancer growth under intermittent androgen suppression therapy

AIP Advances

Volumn 2, Issue 1, 2012, Pages

  Portz, Travis ^a,d   Kuang, Yang ^b   Nagy, John D ^c  

^a ARIZONA STATE UNIVERSITY   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c Scottsdale Community College   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; CELL CULTURE; CELL PROLIFERATION; PATIENT TREATMENT; POPULATION STATISTICS; UROLOGY;

ANDROGEN SUPPRESSION; CELL POPULATIONS; CLINICAL STUDY; HORMONE THERAPY; PRELIMINARY MODEL; PROSTATE CANCERS; PROSTATE SPECIFIC ANTIGEN; QUALITY OF LIFE;

DISEASES;

EID: 84861890001     PISSN: None     EISSN: 21583226     Source Type: Journal    
DOI: 10.1063/1.3697848     Document Type: Article

References (27)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M. Thun, CA Cancer J. Clin. 59, 225 (2009).
2. R. Berges, J. Vukanovic, J. Epstein, M. CarMichel, L. Cisek, D. Johnson, R. Veltri, P. Walsh, and J. Isaacs, Clin. Cancer Res. 1, 473 (1995).
3. C. Heinlein and C. Chang, Endocrine Rev. 25, 276 (2004).
4. N. Craft, C. Chhor, C. Tran, A. Belldegrun, J. DeKernion, O. Witte, J. Said, R. Reiter, and C. L. Sawyers, Cancer Res. 59, 5030 (1999).
5. N. Sharifi, J. Gulley, and W. Dahut, Jama 294, 238 (2005).
6. U. Tunn, BJU Int. 99, 19 (2007).
7. L. Klotz, H. Herr, M. Morse, and W. Whitmore Jr., Cancer 58, 2546 (1986).
8. K. Akakura, N. Bruchovsky, S. Goldenberg, P. Rennie, A. Buckley, and L. Sullivan, Cancer 71, 2782 (1993).
9. J. Crook, E. Szumacher, S. Malone, S. Huan, and R. Segal, Urology 53, 530 (1999).
10. S. Goldenberg, N. Bruchovsky, M. Gleave, L. Sullivan, and K. Akakura, Urology 45, 839 (1995).
11. N. Bruchovsky, L. Klotz, J. Crook, N. Phillips, J. Abersbach, and S. Goldenberg, Clin. Cancer Rev. 2, 82 (2008).
12. F. Schröder, Eur. J. Cancer 45, 402 (2009).
13. T. Jackson, Discrete Cont. Dyn. Syst. Ser. B 4, 187 (2004).
14. A. Ideta, G. Tanaka, T. Takeuchi, and K. Aihara, J. Nonlinear Sci. 18, 593 (2008).
15. M. Grossmann, H. Huang, and D. Tindall, J. Nat. Cancer Inst. 93, 1687 (2001).
16. Y. Hirata, N. Bruchovsky, and K. Aihara, J. Theor. Biol. 264, 517 (2010).
17. Y. Hirata, M. di Bernardo, N. Bruchovsky, and K. Aihara, Chaos 20, 045125 (2010).
18. G. Dimonte, J. Theor. Biol. 264, 420 (2010).
19. S. Eikenberry, J. Nagy, and Y. Kuang, Biology Direct 5 (2010).
20. K. Swanson, L. True, D. Lin, K. Buhler, R. Vessella, and J. Murray, Am. J. Pathol. 158, 2195 (2001).
21. See supplementary material at http://dx.doi.org/10.1063/1.3697848 for a formulation of the Ideta model, parameter range tables, and interpolated androgen data plots.
22. M. Droop, J. Mar. Biol. Assoc. UK 48, 689 (1968).
23. A. Packer, Y. Li, T. Andersen, H. Qiang, Y. Kuang, and M. Sommerfeld, Bioresource Tech. 102, 111 (2011).
24. M.-E. Taplin and S. Balk, J. Cellular Biochem. 91, 483 (2004).
25. K. Lamont and D. Tindall, Mol. Endocrinol. 25, 897 (2011).
26. B. Feldman and D. Feldman, Nat. Rev. Cancer 1, 34 (2001).
27. N. Bruchovsky, L. Klotz, J. Crook, and S. Goldenberg, Cancer 109 (2007).